|
Alibaba Health Information Tech Ltd is a digital healthcare and pharmaceutical e-commerce platform operating within the Alibaba ecosystem. The company's core business comprises three segments: direct online pharmacy sales, a pharmaceutical e-commerce marketplace, and healthcare and digital services. Its direct-sales business, branded as Alibaba Health Pharmacy, offers prescription drugs, over-the-counter medications, health supplements, and medical devices through integrated online stores. The marketplace segment, Tmall Health, aggregates brand flagship stores, chain pharmacies, and medical device vendors to provide a one-stop shopping experience. The healthcare services segment includes an internet hospital platform offering online consultations, chronic disease management, and traditional Chinese medicine services via the Xiaolu TCM platform. The company also provides digital solutions for hospitals, pharmaceutical companies, and insurers, including internet hospital construction, prescription flow, and supply chain management. Notable technologies include the Ali-Doctor medical AI model and the Ma Shang Fang Xin drug traceability platform. Strategic partnerships include collaborations with Novo Nordisk for chronic disease care and the BMJ Group for medical AI. The company serves consumers and institutional clients across China, leveraging platforms such as Tmall, Taobao, Alipay, and DingTalk. Summarised from the company's own disclosures, fiscal year ended Jul 2026 |
Industry Health Information Services | Homepage alihealth.cn |
| Sector Healthcare | IR page — | |
|
Tags
pharmaceutical e-commerce, internet hospital, chronic disease management, traditional chinese medicine, medical ai, drug traceability, digital health, online pharmacy, healthcare services, supply chain management, Alibaba Health Pharmacy, Tmall Health, Xiaolu TCM, Ali-Doctor, Ma Shang Fang Xin, Hongyun Jiukang, Guangzhou Defu Alibaba Health Pharmacy, Ali Health Technology (Hainan), Hangzhou Defu Health Management, Ali JK ZNS (HK)
|
Press page alihealth.cn/en/news |
Metrics
| Valuation | |
|---|---|
| Market cap | HK$ 43.26B |
| Market cap (USD) | $ 5.513B |
| P/E | 19.51 |
| PEG | 0.36 |
| P/BV | 2.05 |
| P/S | 1.07 |
| P/OCF | 29.72 |
| P/FCF | — |
| Dividend yield | 8.4% |
| Turnover / mcap | 0.49% |
| Returns | |
|---|---|
| ROE | 11.3% |
| ROI | 10.8% |
| ROIC | 10.8% |
| Profit margin | 5.7% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | 53.7% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | Yes |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 52.9% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2026 CNY | FY 2025 CNY | FY 2024 CNY | FY 2023 CNY | FY 2022 CNY | FY 2021 CNY | FY 2020 CNY | FY 2019 CNY | FY 2018 CNY | FY 2017 CNY | FY 2016 CNY | FY 2015 CNY | FY 2014 HKD | FY 2013 HKD | FY 2012 HKD | FY 2011 HKD | FY 2010 HKD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34.255B | 30.598B | 27.027B | 26.763B | 20.578B | 15.518B | 9.596B | 5.096B | 2.443B | 475.078M | 56.595M | 29.744M | 60.215M | 489.885M | 481.663M | 372.132M | 287.56M |
| Net profit | 1.936B | 1.432B | 883.477M | 533.407M | -265.555M | 348.588M | -6.586M | -81.949M | -106.974M | -207.626M | -191.608M | -81.221M | -6.472M | -41.344M | -7.735M | -26.35M | -51.516M |
| Figure | FY 2026 CNY | FY 2025 CNY | FY 2024 CNY | FY 2023 CNY | FY 2022 CNY | FY 2021 CNY | FY 2020 CNY | FY 2019 CNY | FY 2018 CNY | FY 2017 CNY | FY 2016 CNY | FY 2015 CNY | FY 2014 HKD | FY 2013 HKD | FY 2012 HKD | FY 2011 HKD | FY 2010 HKD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 3.79 | 4.23 | 3.14 | 6.65 | 3.89 | 20.11 | 10.72 | 6.63 | 3.39 | — | — | — | — | — | — | — | — |
| Price performance 12m | -0.06 | 0.35 | -0.54 | 0.54 | -0.8 | 0.98 | 0.59 | 0.88 | — | — | — | — | — | — | — | — | — |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpAnnouncements and reports published on HKEXnews, newest first, monthly and next-day returns, proxy forms and board-meeting notices included. The link opens the announcement on HKEXnews. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Alibaba Health Information Tech Ltd
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVSE | 0.02% | 86,000 | $ 31.879K | Nov 16, 2026 |
| DFSE | 0.02% | 304,000 | $ 113.351K | Nov 12, 2026 |
| DFEM | 0.02% | 3,854,000 | $ 1.437M | Nov 12, 2026 |
| DFAE | 0.01% | 3,262,000 | $ 1.216M | Nov 12, 2026 |
| NTSE | 0.01% | 12,000 | $ 4,713.05 | Jun 30, 2026 |
| DFAX | 0.00% | 838,000 | $ 312.461K | Nov 12, 2026 |
| AVEM | 0.00% | 644,000 | $ 238.721K | Nov 16, 2026 |